Anti-CGRP Monoclonal Antibody Use for Migraine
The following is a summary of “Effectiveness and safety of anti-CGRP monoclonal antibodies for migraine in patients over 65 years: a systematic review,” published in the March 2025 issue of Pain Management by Muñoz-Vendrell et al. Researchers conducted a...